AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 273: E1127-E1132, 1997;
0193-1849/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fragner, P.
Right arrow Articles by Aratan-Spire, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fragner, P.
Right arrow Articles by Aratan-Spire, S.
Vol. 273, Issue 6, E1127-E1132, December 1997

A new biological contribution of cyclo(His-Pro) to the peripheral inhibition of pancreatic secretion

Pascal Fragner1, Olivier Presset2, Nicole Bernad3, Jean Martinez3, Claude Roze2, and Sonia Aratan-Spire1

1 Institut National de la Santé et de la Recherche Médicale Unité 30, Mécanisme d'Action Cellulaire des Hormones, Hôpital Necker-Enfants-Malades, Tour Lavoisier, 75743 Paris Cedex 15; 2 Institut National de la Santé et de la Recherche Médicale Unité 410, Neuroendocrinologie et Biologie Cellulaire Digestives, 75870 Paris Cedex 18; and 3 Centre National de la Recherche Scientifique 5075, Université de Montpellier I et II, Laboratoire des Aminopeptides, Peptides et Proteines, Faculté de Pharmacie, 34060 Montpellier Cedex, France

The tripeptide pyro-Glu-His-Pro-NH2 [thyrotropin-releasing hormone (TRH)] was isolated from the hypothalamus as a thyrotropin-releasing factor. It has a broad spectrum of central nervous system-mediated actions, including the stimulation of exocrine pancreatic secretion. TRH is also synthesized in the endocrine pancreas and found in the systemic circulation. Enzymatic degradation of TRH in vivo produces other bioactive peptides such as cyclo(His-Pro). Because of the short half-life of TRH and the stability of cyclo(His-Pro) in vivo, we postulated that at least part of the peripheral TRH effects on the exocrine pancreatic secretion may be attributed to cyclo(His-Pro), which has been shown to have other biological activities. This study determines in parallel the peripheral effects of TRH and cyclo(His-Pro) as well as the putative contribution of other TRH-related peptides on exocrine pancreatic secretion in rats. TRH and its metabolite cyclo(His-Pro) dose dependently inhibited 2-deoxy-D-glucose (2-DG)-stimulated pancreatic secretion. TRH and all the related peptides tested had no effect on the basal and cholecystokinin-stimulated amylase release from pancreatic acinar cells in vitro. These data indicate that cyclo(His-Pro) mimics the peripheral inhibitory effect of TRH on 2-DG-stimulated exocrine pancreatic secretion. This effect is not detected on isolated pancreatic acini. Our findings provide a new biological contribution for cyclo(His-Pro) with potential experimental and clinical applications.

thyrotropin-releasing hormone; histidyl-proline diketopiperazine, thyroliberinase; serum pyroglutamyl aminopeptidase; methyl thyrotropin-releasing hormone





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online